NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
Back to search
Official data from USPTO
KARRATIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/02/2024
Trademark type
Combined
Nice classes
5, 42
Filing date
08/18/2021
Registration date
01/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
01/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
03
Owner location
Seoul, KR
Examiner
NOVAKOVIC, MIROSLAV
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a circle design having three sections with colors of purple, orange and red and the word of "Karratio" in red.
Holders and representatives
Holders
Eutilex Co., Ltd.
Representatives
Jong Park THE PL LAW GROUP, PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cells; medicines for human purposespharmaceutical preparations for the treatment of cancer or immune disease; living cells for medical purposes; living cells for veterinary purposes; cellschimeric antigen receptor T-cell (CAR-T)for medical purposes; pharmaceutical preparations for activating cellular function; preparations of microorganisms for medical purposes; biological preparations for medical or veterinary purposespharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for health carepharmaceutical preparations for the treatment of cancer or immune disease; vaccines; colostralmurinechimerichumanizedhumanmonoclonalpolyclonal antibodies for veterinary purposes; antibodies for medical purposes; drugs for medical purposespharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for the treatment of cancers with T cells
Class 42
Product development in the field of cell therapy; research relating to pharmaceuticals; pharmaceutical drug development services; research and development of pharmaceuticals; research and development of vaccines; cell separation research services; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; genetic testingbiological information checkfor medical research use; product developmentbiologics development; research in the field of biologics; biological analysis; biological research; research in the field of gene analysis; genetic research; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/29/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2023
ALIE
ASSIGNED TO LIE
08/26/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/14/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/30/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/30/2023
CNSI
SUSPENSION INQUIRY WRITTEN
03/30/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/30/2022
GNSL
LETTER OF SUSPENSION E-MAILED
09/30/2022
CNSL
SUSPENSION LETTER WRITTEN
09/30/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/30/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/29/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/26/2022
GNRT
NON-FINAL ACTION E-MAILED
05/26/2022
CNRT
NON-FINAL ACTION WRITTEN
05/26/2022
DOCK
ASSIGNED TO EXAMINER
05/19/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2021
NWAP
NEW APPLICATION ENTERED
08/21/2021
Continuous trademark protection
Get notified about every new filing that threatens KARRATIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.